Ki-67 is a protein found in the nucleus of cancer cells that are actively growing and dividing. For breast cancer, Ki-67 is one of the main tumor biomarkers that your healthcare provider will check ...

Background: Ki-67 expression is a well-established prognostic marker in various cancers. However, Ki-67 expression is also known as being heterogeneous. We investigated the prognostic significance ...

A high omega-3, low omega-6 diet with fish oil reduced the Ki-67 index by 15% in prostate cancer patients on active surveillance. The control group showed a 24% increase in the Ki-67 index, ...

Abstract: Nuclear protein Ki-67 and tumor-infiltrating lymphocytes (TILs) are key markers for histopathological diagnosis. They help to predict disease progression, patient prognosis, and treatment ...

Promising early activity in suppressing the Ki-67 protein in both premenopausal and postmenopausal patients with hormone receptor (HR)-positive, HER2-negative, locally advanced breast cancer was ...

An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask. The speed at which cancer cells grow can be an ...

Ki‐67 is a chromatin‐associated protein with a dynamic distribution pattern throughout the cell cycle and is thought to be involved in chromatin organization. The lack of genomic interaction maps has ...

Objective: The Ki-67 index is used to evaluate cell proliferation activity, which is related to tumor progression, metastasis, and prognosis. We aimed to explore the prognostic value of Ki-67 index in ...

Researchers described the case of a 71-year-old male who was diagnosed with a gastrointestinal stromal tumor (GIST) with 10% of the tumor cells showing positive staining for Ki-67, as published in ...

(RTTNews) - Agilent Technologies Inc. (A) Wednesday said that the U.S. Food and Drug Administration approved its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) as an aid in identifying patients with early ...